BPA - AB QuantStudio 5 (ABI 7500 replace)

This contract involves the procurement of AB QuantStudio 5 units to replace the existing ABI 7500 PCR systems across seven microbiology laboratories operated by the Food and Drug Administration. The replacement is necessary due to the discontinuation of service and manufacturing of the ABI 7500 by the current vendor. These instruments are critical for DNA and RNA screening and detection within the labs, ensuring continued capability for accurate molecular testing. The contract covers a base order plus four option years, indicating a long-term commitment to updating and maintaining this essential laboratory equipment. The purchase falls under NAICS code 334516, which relates to analytical laboratory instrument manufacturing. The solicitation was posted on March 11, 2026, and appears to be a forecast opportunity, meaning the procurement is planned but the formal solicitation details are not yet finalized. The contracting point of contact is an acquisition liaison at the FDA, with the contracting officer position still to be determined. The contract aims to secure reliable replacement instrumentation to sustain crucial microbiology testing functions within the agency’s facilities.